DE
56
-2
AMP
52
-2
CTSH
52
-3
V
66
10
EQR
42
-3
SWKS
48
-2
MAS
56
-6
VRSK
66
3
DTE
49
2
BAC
45
-2
AVB
55
-4
PRGO
32
-3
EXR
53
-2
ESS
57
-2
CTAS
49
3
T
47
2
KLAC
54
-3
ZBH
60
-2
QCOM
51
-5
PCAR
55
3
DE
56
-2
AMP
52
-2
CTSH
52
-3
V
66
10
EQR
42
-3
SWKS
48
-2
MAS
56
-6
VRSK
66
3
DTE
49
2
BAC
45
-2
AVB
55
-4
PRGO
32
-3
EXR
53
-2
ESS
57
-2
CTAS
49
3
T
47
2
KLAC
54
-3
ZBH
60
-2
QCOM
51
-5
PCAR
55
3
Financhill
Back

Soleno Therapeutics Quote, Financials, Valuation and Earnings

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
60

SLNO
Soleno Therapeutics

Last Price:
47.19
Seasonality Move:
42.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE

Soleno Therapeutics Price Quote

$47.19
-0.16 (-0.34%)
(Updated: December 11, 2024 at 5:20 PM ET)

Soleno Therapeutics Key Stats

Buy
60
Soleno Therapeutics (SLNO) is a Buy
Day range:
$46.53 - $48.83
52-week range:
$35.04 - $60.92
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2,244.76
P/B ratio:
7.71%
Volume:
698.9K
Avg. volume:
628.5K
1-year change:
27.97%
Market cap:
$2B
Revenue:
$0
EPS:
$-3.35

How Much Does Soleno Therapeutics Make?

Data Unavailable

Is Soleno Therapeutics Growing As A Company?

Data Unavailable

Soleno Therapeutics Stock Price Performance

What Is Soleno Therapeutics 52-Week High & Low?

Soleno Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Soleno Therapeutics?

Is Soleno Therapeutics Cash Flow Positive?

  • What Is SLNO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$51.4M
  • What Is Soleno Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $279.5M
  • What Is Soleno Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$232.1M

Soleno Therapeutics Return On Invested Capital

Data Unavailable

Soleno Therapeutics Earnings Date & Stock Price

Soleno Therapeutics Competitors

  • Who Are Soleno Therapeutics's Competitors?
    Below is a list of companies who compete with Soleno Therapeutics or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • KalVista Pharmaceuticals Inc (KALV)
    • Kronos Bio Inc (KRON)
    • PTC Therapeutics Inc (PTCT)
    • Vertex Pharmaceuticals Inc (VRTX)

Soleno Therapeutics Dividend Yield

Soleno Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 74.25
Upside from Last Price: 56.81%

Major Shareholders

  • How many SLNO shares are owned by institutional investors?
    73.8M SLNO shares are owned by institutional investors
  • How many SLNO shares are owned by insiders?
    1.8M SLNO shares are owned by insiders